ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM
ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM
Active, not recruiting · NCT05283109 · Registry updated 2026-04-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, malignant glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 1 | 2026-04-30 | NCT05283109 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mustafa Khasraw, MBChB, MD, FRCP, FRACP | 2 |
| National Cancer Institute (NCI) | 3015 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Preston Robert Tisch Brain Tumor Center at Duke University | Durham | United States | 2 |